Quan Anh Vu is Chief Financial Officer of Monopar Therapeutics. Currently has a direct ownership of 1,500 shares of MNPR, which is worth approximately $117,000. The most recent transaction as insider was on Dec 26, 2025, when has been sold 1,500 shares (Common Stock) at a price of $69.95 per share, resulting in proceeds of $104,925. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.5K
n/a 3M change
n/a 12M change
Total Value Held $117,000

Quan Anh Vu Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 26 2025
BUY
Open market or private purchase
$104,925 $69.95 p/Share
1,500 Added 50.0%
1,500 Common Stock

Also insider at

ATNF
180 Life Sciences Corp. Healthcare
QAV

Quan Anh Vu

Chief Financial Officer
Palo Alto, CA

Track Institutional and Insider Activities on MNPR

Follow Monopar Therapeutics and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MNPR shares.

Notify only if

Insider Trading

Get notified when an Monopar Therapeutics insider buys or sells MNPR shares.

Notify only if

News

Receive news related to Monopar Therapeutics

Track Activities on MNPR